Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of Life Measures
May 01, 2015 at 07:34 AM EDT
Abstract #116 Celgene Corporation (NASDAQ: CELG) today announced results from a pre-specified secondary endpoint analysis of ...